Dr. Pradeep Natarajan is the Director of Preventive Cardiology and the Paul and Phyllis Fireman Endowed Chair in Vascular Medicine at Massachusetts General Hospital, Associate Director of Personalized Medicine at Mass General Brigham, Associate Professor of Medicine at Harvard Medical School, and Associate Member of the Broad Institute of Harvard and MIT. His research program spans the MGH Cardiovascular Research Center, MGH Center for Genomic Medicine, and Broad Institute of Harvard and MIT. He uses germline and somatic genetic variation to uncover new biology and enable enhanced clinical care for cardiovascular disease. He leads several consortia to use genetic epidemiology, large-scale sequencing studies, genotype-driven human investigation, and genetic testing implementation. He is an Associate Editor for JAMA Cardiology and Science Advances. He is an elected member of the American Society for Clinical Investigation and the Association of American Physicians. He has been awarded the Jeffrey M. Hoeg and Joseph A. Vita Awards by the American Heart Association for his contributions. In tandem with his research efforts, Dr. Natarajan oversees clinical and training programs on the prevention of cardiometabolic diseases leading the MGH Cardiovascular Disease Prevention Center, and health system-wide innovative clinical paradigms via the MGB Personalized Medicine.

Peter P. Toth, MD, PhD is Director of Preventive Cardiology at the CGH Medical Center in Sterling, Illinois, USA. He is Professor of Clinical Family and Community Medicine at the University of Illinois School of Medicine and Adjunct Professor of Medicine at the Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine. Dr. Toth is a past president of the National Lipid Association, the American Board of Clinical Lipidology, and the American Society for Preventive Cardiology. He is the immediate past chair of the American Heart Association’s Council on Lipids, Lipoproteins, and Thrombosis and is a member of the American College of Cardiology’s Board of Councilors. Dr. Toth has authored and co-authored over 500 publications in medical and scientific journals and textbooks. He is Series Editor of Springer’s textbook collection in Contemporary Cardiology. He has edited and written 23 textbooks on various aspects of cardiovascular medicine. He has lectured on many topics in cardiovascular medicine throughout the world.

MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS Director of Victorian Heart Hospital, MonashHeart & ICU, Monash Health Director of Victorian Heart Institute, Monash University Professor of Cardiology, Monash University Professor Steve Nicholls is the inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He is the inaugural Director of the Victorian Heart Hospital which opened in February 2023. Steve is a preventive cardiologist. His clinical interest is focused on identifying those at risk of heart disease earlier, and more effectively, and preventing catastrophic cardiovascular events from occurring. He is committed to solutions which improve equity across risk and management, focusing on women’s heart health and other under-served populations. His work spans the translational spectrum from the lab bench to the bedside, with a focus on understanding the factors that promote plaque formation, novel vascular imaging and leadership of large-scale clinical trials of new therapies designed to reduce the risk of heart disease. He is Chair of the Asia Pacific Cardiometabolic Consortium, past-President of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.

Gemma is a Professor in Medicine at the University of Sydney and an Interventional Cardiologist at Royal North Shore Hospital in Sydney. She is the Chair of the University of Sydney’s multi-disciplinary Cardiovascular Initiative. Gemma is committed to improving the care for heart attack patients, unravelling key mechanisms underlying susceptibility and response to heart attack, with studies extending from the bench to large cohort studies and clinical trials. Discoveries in her Laboratory have been published in leading journals including the Lancet, Circulation, JACC and European Heart Journal, with > 250 publications. Gemma is a principal investigator on grants >$42 Mill. Her discoveries and innovative strategies have resulted in a US patent, and 5 provisional patents spanning diagnostic and therapeutic fields. Gemma is founder and CSO for Australian start-ups Prokardia and Kardiomics, and the not-for-profit CAD Frontiers Pty Ltd. She was awarded a National Health and Medical Research Council (NHMRC) Excellence Award for Top Ranked Practitioner Fellow (Australia- 2018), NSW Ministerial Award for Cardiovascular Research Excellence (2019) and was the second female to be awarded the prestigious Cardiac Society of Australia and New Zealand RT Hall Prize for outstanding and sustained research achievement (2023). Gemma serves as a member of the Editorial Board of leading international journals including Circulation and Cardiovascular Research and an Associate Editor for Heart, Lung and Circulation. She is a passionate advocate for cardiovascular research, working as President of the Australian Cardiovascular Alliance with a national team to secure $220 Million Federal funding for the Mission for Cardiovascular Health, and to build new pathways for research to best serve the unmet health needs of Australians. She chairs the MRFF Mission (CV) Expert Advisory Panel. She is a graduate of the Australian Institute of Company Directors and serves/has served as a non-executive Director on multiple community Boards, including the Heart Foundation. In 2023, Gemma was appointed a Member of the Order of Australia (AM), in the Australia Day Honours.

Dr Ari Horton is a paediatric cardiologist and senior clinical genetics fellow. He is passionate about precision- and evidence-based care for children and families with congenital heart disease, inherited cardiac disease and lipid disorders. He is interested in developing rapid and ultra-rapid genomic sequencing for critically unwell cardiac patients to inform management and change outcomes. Together with his colleagues, Dr Horton is working towards innovative ways to improve equity of access and introduce genetic testing into the mainstream, whilst advocating for shared-care and multidisciplinary models to best address the needs of Australian and international communities.

Dr Elizabeth Robertson is a clinical-academic Cardiologist at Royal Prince Alfred Hospital, Sydney, who has a special interest in genetically triggered vascular disease including inherited aortic syndromes and familial hypercholesterolaemia.